GMPPB and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Differently from other dystroglycanopathies, GMPPB mutations can lead to a defect of neuromuscular transmission and congenital myasthenic syndrome due to altered glycosylation of the acetylcholine receptor subunits and other synaptic proteins [8,9,10].